Header cover image

South Korean Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED Sep 24, 2023

Companies with a Value score of at least 3, ordered by Value score

31 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
A214450PharmaResearch₩119,900.00-4.2%108.5%₩1.2t₩158,750.00PE22xE20.0%0.6%
A145020Hugel₩122,300.00-0.6%16.1%₩1.4t₩155,428.57PE20.6xE17.5%n/a
A003220Daewon Pharmaceutical₩16,380.00-5.3%11.8%₩345.6b₩21,000.00PE10.8xE1.9%2.1%
A038290Macrogen₩18,800.00-1.7%-0.5%₩189.0b₩30,000.00PS1.4xE128.9%1.6%
A096530Seegene₩20,800.00-8.4%-18.6%₩991.2b₩27,000.00PS2.2xE103.7%3.8%
A185750Chong Kun Dang Pharmaceutical₩92,600.00-1.4%27.3%₩1.1t₩105,714.29PE9.4xE-10.3%1.0%
A069620Daewoong pharmaceuticalLtd₩103,900.00-4.2%-31.4%₩1.2t₩159,300.00PE23.3xE31.8%0.6%
A023910Daihan PharmaceuticalLtd₩27,650.00-1.3%11.0%₩164.3b₩40,000.00PE6.1xE8.9%2.4%
A950200Psomagen₩5,580.00-7.3%-6.2%₩110.0bn/aPS2.7xn/an/a
A106190High Tech Pharm₩15,540.000%64.8%₩111.0bn/aPE13.9xn/an/a
A359090C&R Research₩1,220.00-10.7%-5.4%₩67.2bn/aPE15.7xn/an/a
A086450DongKook Pharmaceutical₩15,060.00-0.6%-8.2%₩662.8b₩20,000.00PE14xE19.8%1.2%
A256840BNC Korea₩3,950.00-4.1%-35.9%₩256.2bn/aPS4xn/an/a
A003090Daewoong₩14,210.00-1.7%-29.5%₩595.9bn/aPE4.8xn/a0.7%
A009300Sam-A Pharm₩16,490.00-1.6%11.4%₩99.7bn/aPE4.9xn/a2.4%
A003120Ilsung Pharmaceuticals₩21,150.00-4.1%0.7%₩147.7bn/aPE7.7xn/a18.9%
A049960Cell Biotech₩11,260.00-3.1%1.9%₩76.8bn/aPE28.2xn/a4.0%
A014570Korean Drug₩6,510.00-5.5%-6.9%₩71.9bn/aPE13xn/a2.8%
A200780BCWORLD PHARM₩6,560.000%-4.0%₩55.1bn/aPE9.8xn/a1.5%
A084650LabGenomics₩4,630.00-15.0%67.8%₩358.6bn/aPE25.4xn/a1.1%
A001630Chong Kun Dang Holdings₩53,000.00-0.7%3.7%₩258.6b₩63,000.00PE10.4xE-37.8%2.6%
A377740BioNote₩4,715.00-7.0%n/a₩487.8bn/aPS3.6xn/a10.4%
A251120BIO-FD&CLtd₩13,480.00-8.8%-16.8%₩119.8bn/aPE27xn/an/a
A347740P&K Skin Research Center₩2,825.00-4.7%-18.0%₩84.8bn/aPE11.9xn/an/a
Page 1 of 2